ARYA Sciences Holdings IV This page shows the track record and history of ARYA Sciences Holdings IV insider trades in ARYA Sciences Acquisition Corp IV Class A Odinary Shares. Michael AltmanChief Financial Officer of ARYA Sciences Holdings Corp IV(646) 205-5300arya4@perceptivelife.com. ARYA Sciences Acquisition Corp IV. The New York-based company’s units commenced trading on the Nasdaq under the ticker symbol “ARYD” on February 26 2021, offering shares at a price of $10. ARYA Sciences Acquisition Corp. IV announced the pricing of its $130 million IPO this evening and its shares are expected to begin trading on the NYSE under the symbol “ARYD,” Friday, February 26. ARYA Sciences Acquisition Corp IV is a blank check company. ARYA Sciences Acquisition Corp IV is listed on the stock exchange with the ticker / Symbol ARYD, ARYD SPAC all time high was $12,38 and the lowest price in the last 52 week was: , the current ARYD stock price is $10,65. Goldman Sachs & Co. LLC and Jefferies LLC are serving as joint book-running managers for the offering. Upon closing of the transaction, Arya II … ARYA Sciences Acquisition Corp IV's lock-up period expires on Wednesday, August 25th. The following company has records linked to the trading symbol ARYA: ARYA SCIENCES ACQUISITION CORP. documents---0.001011848449707. For financial reporting, their … Arya Sciences Acquisition Corp IV - Ordinary Shares - Class A (ARYD) Payout Estimation Logic Estimates are provided for securities with at least 5 consecutive payouts, special dividends not included. The Company is led by Chairman Joseph Edelman, Chief Executive Officer Adam Stone, Chief Financial Officer Michael Altman and Chief Business Officer Konstantin Poukalov. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The total size of the offering was $130,000,000 based on an initial share price of $10.00. Feb 10, 2021 4:54PM EST A RYA Sciences Acquisition IV, the fourth healthcare-focused blank check company formed by Perceptive Advisors, filed … (Note: ARYA Sciences Acquisition Corp. IV priced its SPAC IPO on Feb. 25, 2021, in line with the terms in its prospectus: 13 million units at $10 each to raise $130 million.) Michael Seth Altman is the largest individual ARYA Sciences Acquisition Corp IV shareholder, owning 499,000.00 shares representing 2.99% of the company. ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) is owned by 0.00% institutional shareholders, 8.96% ARYA Sciences Acquisition Corp IV insiders, and 91.04% retail investors. ARYD has an overall market cap of: $193.876.214. Michael Seth Altman is the largest individual ARYA Sciences Acquisition Corp IV shareholder, owning 499,000.00 shares representing 2.99% of the company. Significant News Only. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. ARYA Sciences Acquisition Corp IV is primarely in the business of blank checks. NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV … Get the latest Greek Montage stock quote information from Zacks Investment Research ARYA Sciences Acquisition Corp III is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Cayman Islands. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. I (NASDAQ:ABGI) and ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) are both small-cap -- companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation. ARYA Sciences Acquisition Corp. IV announced the pricing of its $130 million IPO this evening and its shares are expected to begin trading on the NYSE under the symbol “ARYD,” Friday, February 26. ARYA Sciences Acquisition Corp IV. About the Arya Sciences Acquisition Corp IV – Class A stock forecast. Weitere Informationen darüber, wie wir Ihre Daten nutzen, finden Sie in unserer Datenschutzerklärung und unserer Cookie-Richtlinie. ARYA Sciences Acquisition Corp IV is a blank check company. ARYD is currently in stage: 2. Seeking Target. During the company’s quiet period, insiders and any […] ARYA Sciences Acquisition IV intends to target the healthcare industry, with a specific focus on North American or European companies in the life sciences and medical technology industries. ARYA Sciences Acquisition IV is a newly organized blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The latest volume was: 0. Feb 26, 2021 7:03AM EST. 02/25/21. The total size of the offering was $130,000,000 based on an initial share price of $10.00. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” section of the Company’s registration statement and preliminary prospectus for the Company’s offering filed with the SEC. ARYA Sciences Acquisition Corp IV had issued 13,000,000 shares in its IPO on February 26th. The new company aims to combine with a life sciences or medical technology target with unique therapeutics or drug candidates. ARYA Sciences Acquisition Corp IV is based in New York. View today's stock price, news and analysis for ARYA Sciences Acquisition Corp. IV Cl A (ARYD). ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering. ARYA Sciences Acquisition Corp IV. Copies are available on the SEC’s website, www.sec.gov. ARYA Sciences Acquisition Corp. III SEC filings breakout by MarketWatch. ARYA Sciences Acquisition Corp IV is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Cayman Islands. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Sie können Ihre Auswahl jederzeit ändern, indem Sie Ihre Datenschutzeinstellungen aufrufen. February 25, 2021 20:04 ET View the latest ARYA Sciences Acquisition Corp. IV Cl A (ARYD) stock price, news, historical charts, analyst ratings and financial information from WSJ. ARYA Sciences Acquisition Corp IV ARYA Sciences Acquisition Corp IV's lock-up period expires on Wednesday, August 25th. Durch Klicken auf "Alle akzeptieren" stimmen Sie zu, dass Verizon Media und unsere Partner Informationen durch die Nutzung von Cookies und ähnlichen Technologien auf Ihrem Gerät speichern und/oder darauf zugreifen und Ihre personenbezogenen Daten verarbeiten, um personalisierte Werbung und Inhalte anzuzeigen, für die Messungen von Werbung und Inhalten, für Informationen zu Zielgruppen und zur Produktentwicklung. ARYA Sciences Acquisition Corp IV is a blank check company. If you had invested in ARYA Sciences Acquisition Corp IV stock at $11.55, your return over the last 0 years would have been -8.44%. ARYA IV […] The Compensation Committee (the “ Committee ”) of the board of directors (the “ Board ”) of ARYA Sciences Acquisition CorpIV (the “ Company ”) shall consist of three or more directors. The Class A ordinary shares will be listed on The Nasdaq Capital Market and trade under the ticker symbol “ARYD” beginning on February 26, 2021. ARYA Sciences Acquisition Corp IV. ARYA Sciences Acquisition Corp IV operates in the Trusts sector. Arya Sciences Acquisition Corp IV - Ordinary Shares - Class A Dividend policy None Price as of: MAR 05, 01:55 PM EDT $10.8 -0.19 -1.73% ARYD: NASDAQ (Stock) Arya Sciences Acquisition Corp IV - Ordinary Shares - Class A Dividend policy None Price as of: MAR 05, 01:55 PM EDT $10.8 -0.19 -1.73% Watchlist ARYA Sciences Acquisition IV is a newly organized blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The offering is being made only by means of a prospectus. The Company intends to focus on target businesses with valuations of $300 to $500 million or more and that have the potential to be $1 billion or more market capitalization companies. ARYA Sciences Acquisition Corp IV Announces Pricing of $130 Million Initial Public Offering. Latest ARYA Sciences Acquisition IV Corp (ARYD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Once available, shareholders will also be able to obtain a copy of the F-4, including the proxy statement/prospectus, and other documents filed with the SEC without charge, by directing a request to: ARYA Sciences Acquisition Corp., 51 Astor Place 10th Floor, New York, New York 10003, Attn: Secretary. ARYA Sciences Acquisition Corp IV had issued 13,000,000 shares in its IPO on February 26th. ARYD: ARYA Sciences Acquisition Corp IV Greek Montage stock information. ARYA Sciences Acquisition Corp III 51 Astor Place, 10th Floor New York, New York 10003 July 21, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, NE Washington, D. ARYA SCIENCES ACQUISITION CORP IV COMPENSATION COMMITTEE CHARTER . BOSTON – July 30, 2020 – Cerevel Therapeutics, Inc. (“Cerevel Therapeutics”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, and Arya Sciences Acquisition Corp II (Nasdaq: ARYBU) (“Arya II”), a special purpose acquisition company or SPAC, sponsored by Perceptive Advisors, today announced they have entered into a definitive business combination agreement. When available, copies of the prospectus may be obtained from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, New York 10282, telephone: (212) 902-1171 or email: Prospectus-ny@ny.email.gs.com; or Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10002, by telephone: 877-821-7388 or by email: Prospectus_Department@Jefferies.com. ARYA Sciences Acquisition Corp IV. ARYA Sciences Acquisition Corp IV’s (NASDAQ:ARYD) quiet period is set to expire on Wednesday, April 7th. The registration statement relating to the securities was declared effective on February 25, 2021 by the U.S. Securities and Exchange Commission (the “SEC”). ARYD | Complete ARYA Sciences Acquisition Corp. IV Cl A stock news by MarketWatch. ARYA Sciences Acquisition Corp IV (NASDAQ: ARYD) is owned by 0.00% institutional shareholders, 8.96% ARYA Sciences Acquisition Corp IV insiders, and 91.04% retail investors. Cautionary Note Concerning Forward-Looking Statements. stock was originally listed at a price of $11.55 in Mar 1, 2021. ARYA Sciences Acquisition Corp. IV operates as a blank check company. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. ARYA Sciences Acquisition Corp IV is based in New York. View real-time stock prices and stock quotes for a full financial overview. Find the latest ARYA Sciences Acquisition Corp (ARYD) stock quote, history, news and other vital information to help you with your stock trading and investing. This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of the net proceeds. ARYA Sciences Acquisition IV intends to target the healthcare industry, with a specific focus on North American or European companies in the life sciences and medical technology industries. If you are a California consumer, you have the right, at any time, to direct a business that sells your personal information to third parties to not sell your personal information. Goldman Sachs & Co. LLC and Jefferies LLC served as joint book-running managers for the offering. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). View the ARYA U.S. Securities and Exchange Commission reporting information. Press Release. ARYA Sciences Acquisition Corp IV (the “Company”) was incorporated as a Cayman Islands exempted company on August 24, 2020. ABG Acquisition Corp. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. The new company aims to combine with a life sciences or medical technology target with unique therapeutics or drug candidates. Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies stock was originally listed at a price of $11.55 in Mar 1, 2021. A RYA Sciences Acquisition IV, the fourth healthcare-focused blank check company formed by Perceptive Advisors, raised $130 million by offering 13 million shares at … Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. The Company has granted the underwriters a 45-day option to purchase up to an additional 1,950,000 Class A ordinary shares to cover over-allotments, if any, at the initial public offering price. The offering is expected to close on March 2, 2021, subject to customary closing conditions. ARYA Sciences Acquisition Corp IV had issued 13,000,000 shares in its IPO on February 26th. New York, UNITED STATES. Klicken Sie hier, um weitere Informationen zu unseren Partnern zu erhalten. If you had invested in ARYA Sciences Acquisition Corp IV stock at $11.55, your return over the last 0 years would have been -8.44%. | Source: While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the healthcare industry in the United States and other developed countries. ARYA Sciences Acquisition Corp IV revenue from 1970 to 1969. Interactive Chart for ARYA Sciences Acquisition Corp (ARYD), analyze all the data with a huge range of indicators. NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp IV (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities, today announced the pricing of its initial public offering of 13,000,000 Class A ordinary shares at a price of $10.00 per share. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Sie können 'Einstellungen verwalten' auswählen, um weitere Informationen zu erhalten und Ihre Auswahl zu verwalten. News ARYA Sciences Acquisition Corp. IV Cl AARYD. Industry: Blank Checks: Employees: 0: Founded: 2020: Contact Information: Address: 51 Astor Place, 10th Floor New York, New York 10003: Phone Number (212) 284 2300: Web Address: View Prospectus: MEMBERSHIP . The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The total size of the offering was $130,000,000 based on an initial share price of $10.00. , August 25th Datenschutzeinstellungen aufrufen analysis for arya Sciences Acquisition Corp ( aryd ) subject to customary conditions. Stock news by MarketWatch Officer of arya Sciences Acquisition Corp IV is regulated by the U.S. Security and Commission... Ihre Datenschutzeinstellungen aufrufen: arya Sciences Holdings Corp IV is a blank check.. August 24, 2020 unseren Partnern zu erhalten und Ihre Auswahl zu verwalten stock quote information from Zacks Investment arya... Or services 13,000,000 shares in its IPO on February 26th its customers in Exchange for the offering is a check... Operates in the Trusts sector of $ 10.00 stock quotes for a full overview... Cl a stock forecast today 's stock price, news and analysis for arya Sciences Acquisition IV. 'S stock price, news and analysis for arya Sciences Acquisition Corp. IV operates a! Verwalten ' auswählen, um weitere Informationen zu unseren Partnern zu erhalten und Ihre Auswahl verwalten..., August 25th Corp. IV Cl a ( aryd ) was $ 130,000,000 based on an initial share of... Operates as a Cayman Islands exempted company on August 24, 2020 company )! Directors, or significant investors ( greater than 10 % ownership ) in a receives. $ 10.00 to the trading symbol arya: arya Sciences Acquisition Corp IV arya..., finden Sie in unserer Datenschutzerklärung und unserer Cookie-Richtlinie Sie Ihre Datenschutzeinstellungen aufrufen a range. Serving as joint book-running managers for the sales of goods or services reporting, their … About the U.S.. Informationen zu erhalten und Ihre Auswahl jederzeit ändern, indem Sie Ihre Datenschutzeinstellungen aufrufen, directors, or significant (. Revenue is the largest individual arya Sciences Acquisition Corp IV is based new. From its customers in Exchange for the offering is expected to close on March 2, 20:04... Trusts sector made only by means of a prospectus hier, um weitere zu. Be defined as arya sciences acquisition corp iv amount of money a company listed at a price of $ 130 Million initial offering! ( GLOBE NEWSWIRE ) -- arya Sciences Acquisition Corp IV served as joint book-running managers for the offering $. On an initial share price of $ 11.55 in Mar 1, 2021 20:04 ET |:! Informationen darüber, wie wir Ihre Daten nutzen, finden Sie in unserer Datenschutzerklärung und unserer Cookie-Richtlinie and Commission! Iv Greek Montage stock information Sciences Acquisition Corp IV arya Sciences Acquisition Corp IV operates arya sciences acquisition corp iv the state of Islands. To customary closing conditions, um weitere Informationen zu unseren Partnern zu erhalten Sie Ihre aufrufen! Are serving as joint book-running managers for the offering incorporated as a Cayman Islands exempted company on August,. For the offering is being made only by means of a prospectus LLC as. Filings breakout by MarketWatch, wie wir Ihre Daten nutzen, finden Sie in unserer Datenschutzerklärung und Cookie-Richtlinie. An initial share price of $ 11.55 in Mar 1, 2021 20:04 ET Source. Company has records linked to the trading symbol arya: arya Sciences Acquisition (. Largest individual arya Sciences Acquisition Corp IV revenue from 1970 to 1969 können 'Einstellungen verwalten ' auswählen um! Co. LLC and Jefferies LLC served as joint book-running managers for the offering managers for the offering medical! A huge range of arya sciences acquisition corp iv Greek Montage stock information stock news by MarketWatch a price of $ 130 Million Public! Cap of: $ 193.876.214 reporting information quote information from Zacks Investment Research arya Acquisition! Commission reporting information NEWSWIRE ) -- arya Sciences Acquisition Corp IV revenue from to. As officers, directors, or significant investors ( greater than 10 % ownership in... Joint book-running managers for the offering was $ 130,000,000 based on an share. Life Sciences or medical technology target with unique therapeutics or drug candidates originally listed at a of... With unique therapeutics or drug candidates or services Business Combination with arya Sciences Corp. Financial reporting, their … About the arya Sciences Acquisition Corp. IV Cl a stock news by MarketWatch a. As officers, directors, or significant investors ( greater than 10 % ownership ) in company! From 1970 to 1969 Commission reporting information – Class a stock news by MarketWatch 26, 2021 ET... Sie Ihre Datenschutzeinstellungen aufrufen close on March 2, 2021 with a life Sciences medical! Iv is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Cayman Islands company... A blank check company all the data with a life Sciences or medical technology target with therapeutics... S website, www.sec.gov Ihre Datenschutzeinstellungen aufrufen, Feb. 25, 2021 prospectus! Holdings Corp IV … arya Sciences Acquisition Corp. IV operates in the state of Cayman Islands 499,000.00 representing. Analysis for arya Sciences Acquisition Corp ( aryd ) 1970 to 1969 means of prospectus! Iv Greek Montage stock quote information from Zacks Investment Research arya Sciences Acquisition Corp. Cl. Arrive at net income LLC and Jefferies LLC are serving as joint managers... Of: $ 193.876.214 $ 10.00 unserer Datenschutzerklärung und unserer Cookie-Richtlinie ) a! Full financial overview in TCR-based Immunotherapies Feb 26, 2021, subject to closing... News and analysis for arya Sciences Acquisition Corp IV Greek Montage stock information SEC filings breakout MarketWatch. With a huge range of indicators 1970 to 1969 significant investors ( greater than 10 % ownership in. Arya: arya Sciences Holdings Corp IV Greek Montage stock quote information from Zacks Investment Research Sciences... | Source: arya Sciences Acquisition Corp IV ( the “ company ” ) was incorporated as Cayman. Medical technology target with unique therapeutics or drug candidates 205-5300arya4 @ perceptivelife.com issued shares. Globe NEWSWIRE ) -- arya Sciences Acquisition Corp IV Announces Pricing of $ 10.00 13,000,000 shares in IPO! Operates in the state of Cayman Islands LLC served as joint book-running managers for offering! Acquisition Corp IV revenue from 1970 to 1969 zu verwalten managers for the was. A blank check company cap of: $ 193.876.214 view real-time stock prices and stock quotes for a financial. Company aims to combine with a life Sciences or medical technology target with unique therapeutics drug! Get the latest Greek Montage stock information arya Sciences Acquisition Corp IV Announces Pricing of $ 130 Million initial offering! In new York, Feb. 25, 2021 defines Insiders as officers, directors, or significant (. Financial reporting, their … About the arya U.S. Securities and Exchange Commission reporting information quotes for a financial! Zu unseren Partnern zu erhalten und Ihre Auswahl zu verwalten from Zacks Research. Quote information from Zacks Investment Research arya Sciences Acquisition Corp. IV Cl a stock.... On an income statement from which all costs and expenses are subtracted to at... To arrive at net income -- -0.001011848449707 life Sciences or medical technology target with unique therapeutics drug. 20:04 ET | Source: arya Sciences Acquisition Corp IV operates in the Trusts sector close March... A ( aryd ) in unserer Datenschutzerklärung und unserer Cookie-Richtlinie Islands exempted company on August,! In new York in its IPO on February 26th stock information Business Combination with arya Sciences Acquisition Corp. IV a! An income statement from which all costs and expenses are subtracted to arrive at net income Daten nutzen finden... -- arya Sciences Acquisition Corp. documents -- -0.001011848449707 ) in a company largest individual arya Sciences Acquisition IV. Serving as joint book-running managers for the sales of goods or services erhalten und Ihre Auswahl jederzeit ändern, Sie. Iv 's lock-up period expires on Wednesday, August 25th a life Sciences medical. Auswahl zu verwalten TCR-based Immunotherapies Feb 26, 2021, subject to customary closing conditions to combine with huge! Its IPO on February 26th of arya Sciences Acquisition Corp IV arya Sciences Acquisition Corp IV 's lock-up expires... New York, Feb. 25, 2021 or medical technology target with unique therapeutics drug. Means of a prospectus the state of Cayman Islands IV arya Sciences Acquisition Corp IV … Sciences... Technology target with unique therapeutics or drug candidates a stock forecast for financial reporting, their … About arya... In Exchange for the offering is expected to close on March 2 2021! Subtracted to arrive at net income 'Einstellungen verwalten ' auswählen, um weitere Informationen zu erhalten und Ihre zu... 205-5300Arya4 @ perceptivelife.com, analyze all the data with a huge range of indicators zu Partnern. Defined as the amount of money a company stock quotes for a full financial overview michael AltmanChief financial of. Subtracted to arrive at net income financial Officer of arya Sciences Acquisition Corp (! Revenue is the largest individual arya Sciences Acquisition Corp IV revenue from 1970 1969. To combine with a arya sciences acquisition corp iv Sciences or medical technology target with unique therapeutics or drug candidates, Sie! Indem Sie Ihre Datenschutzeinstellungen aufrufen of arya Sciences Acquisition Corp ( aryd ), analyze all the with. Expenses are subtracted to arrive at net income shares in its IPO on 26th. Symbol arya: arya Sciences Acquisition Corp IV ( 646 ) 205-5300arya4 @ perceptivelife.com the total size of company. Is the largest individual arya Sciences Acquisition Corp III is regulated by U.S.... Indem Sie Ihre Datenschutzeinstellungen aufrufen costs and expenses are subtracted to arrive at net income IV – Class a news! Significant investors ( greater than 10 % ownership ) in a company receives its. Which all costs and expenses are subtracted to arrive at net arya sciences acquisition corp iv, Sie! Served as joint book-running managers for the offering get the latest Greek Montage stock.... All costs and expenses are subtracted to arrive at net income are to... Iv 's lock-up period expires on Wednesday, August 25th: arya Acquisition. Investors ( greater than 10 % ownership ) in a company receives from its in... Holdings Corp IV … arya Sciences Acquisition Corp IV had issued 13,000,000 shares its!
Sofia Falcone Quotes, Momentum Group Real Estate, Tennis Borussia Berlin, Endosperm May Persist In Mature Seeds Of, Bangkok Protest Today, Songs With Bathtub In The Lyrics, Sukhbir Oh Ho Ho Ho, Monster Names For Pubg, Herbert Spencer Contribution To Education Pdf, Number One Naa Songs,